ophthalmologyadvisor3d
Susvimo Approval Expanded to Include Diabetic Macular Edema
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia
SALT LAKE CITY, February 05, 2025--iVeena Delivery Systems Inc. ("iVeena"), a biopharmaceutical company advancing IVMED-85 for the treatment of pediatric myopia, today announced that it has closed its ...